[Special Stock] SK Bioscience Rises 3% on Expectations of Vaccine Discussion Meeting with Bill Gates

[Asia Economy Reporter Lee Seon-ae] SK Bioscience is showing an upward trend in the early trading session on the 12th following news that Bill Gates, co-chairman of the Bill & Melinda Gates Foundation and founder of Microsoft (MS), will hold a meeting.

At 9:30 a.m. on the same day, SK Bioscience was trading at 131,000 KRW, up 3.56% compared to the previous trading day.

The news that Chairman Gates is scheduled to meet around the 16th to discuss COVID-19 vaccine production with SK Bioscience is believed to be the reason. As a result, SK Bioscience closed up 4.55%. Previously, Chairman Gates had supported SK Bioscience's COVID-19 vaccine development through the foundation. It is also understood that SK Bioscience is the only company that Chairman Gates will meet during this visit to Korea, which has further raised expectations.